Rushikesh Bhor

Senior Officer @ Alivus Life Sciences | Regulatory Affairs Expertise

Role: Senior Officer at Alivus Life Sciences
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

Manufacturing & ProductionView LinkedIn profile

About Rushikesh Bhor

Regulatory Affairs professional with over 5 years of experience in API regulatory strategy,DMF compilation, review, vendor qualification, and global dossier compliance (US, EU, WHO, Canada).Adept at cross-functional coordination, health authority query management, and post-approvalregulatory support. Recognized with the \"Customer Focus Award 2025\" for excellence inregulatory responsiveness.

Experience

Senior Officer
Alivus Life Sciences
Oct 2025 — Present · Mumbai, IN

Education

Viva college
M.Sc
Bhavans College
B.Sc

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@alivus.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Alivus Life Sciences

Pharmaceutical Manufacturing · 619 employees · Founded 2019 · E Mumbai, Maharashtra, India

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited), is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. The company is increasingly providing CDMO services to a range of multinational and specialty pharmaceutical companies. It has a diversified portfolio of 161 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan, and the Rest of the World (RoW). The company’s four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed capacity of 1424 KL, which are regularly inspected by global regulators such as USFDA, PMDA (Japan) and EDQM (Europe). Alivus Life Sciences is listed on BSE and NSE. The company’s journey as an independent entity began in 2019, branching off from Glenmark Pharmaceuticals to focus solely on building an API business. Since then, the API business has charted a strong course and flourished independently to pave the way for a distinctive growth trajectory. FY24 marked a significant milestone for the company, due to a change of ownership from Glenmark Pharmaceuticals to Nirma. The key differentiator for Alivus is its people. The knowledgeable, responsible and inspired team, of almost employees from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. Powered by its world-class manufacturing and research capabilities, Alivus supplies high-quality APIs to more than 700 pharma companies in over 70 countries. As part of its evolving vision, the company is further strengthening its global presence and committing to provide innovative solutions in the API and CDMO space.

alivus.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Rushikesh Bhor

Experience

Senior Officer

Education

Viva college

Bhavans College

Find verified contacts for anyone on LinkedIn